Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis Mollard

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Inorganic Chemistry|December 5, 2006
Tricarboranyl pentaerythritol-based building blockAlexis Mollard, Ilya Zharov
Inorganic Chemistry|September 12, 2006
Polyester-based carborane-containing dendronsKristin M Galie, Alexis Mollard, Ilya Zharov
Biomed Research International|October 15, 2014
Inhibition of Nek2 by small molecules affects proteasome activityLingyao Meng, Kent Carpenter, Alexis Mollard, et al.
Bioconjugate Chemistry|October 29, 2014
Tumor targeting, trifunctional dendritic wedgeRamin Dubey, Swati Kushal, Alexis Mollard, et al.
ACS Medicinal Chemistry Letters|January 17, 2012
Design, Synthesis and Biological Evaluation of a Series of Novel Axl Kinase InhibitorsAlexis Mollard, Steven L Warner, Lee T Call, et al.
Journal of Drug Targeting|August 4, 2025
Ofirnoflast: a first-in-class NEK7-targeted inhibitor of the NLRP3 inflammasomeAlexis Mollard, Devan Bursey, William Burnett, et al.
Leukemia|November 25, 2023
TP-0184 inhibits FLT3/ACVR1 to overcome FLT3 inhibitor resistance and hinder AML growth synergistically with venetoclaxAnudishi Tyagi, Appalaraju Jaggupilli, Stanley Ly, et al.
Neoplasia (New York, N.Y.)|June 24, 2014
A small-molecule inhibitor of PIM kinases as a potential treatment for urothelial carcinomasJason M Foulks, Kent J Carpenter, Bai Luo, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Inorganic Chemistry|December 5, 2006
Tricarboranyl pentaerythritol-based building blockAlexis Mollard, Ilya Zharov
Inorganic Chemistry|September 12, 2006
Polyester-based carborane-containing dendronsKristin M Galie, Alexis Mollard, Ilya Zharov
Biomed Research International|October 15, 2014
Inhibition of Nek2 by small molecules affects proteasome activityLingyao Meng, Kent Carpenter, Alexis Mollard, et al.
Bioconjugate Chemistry|October 29, 2014
Tumor targeting, trifunctional dendritic wedgeRamin Dubey, Swati Kushal, Alexis Mollard, et al.
ACS Medicinal Chemistry Letters|January 17, 2012
Design, Synthesis and Biological Evaluation of a Series of Novel Axl Kinase InhibitorsAlexis Mollard, Steven L Warner, Lee T Call, et al.
Journal of Drug Targeting|August 4, 2025
Ofirnoflast: a first-in-class NEK7-targeted inhibitor of the NLRP3 inflammasomeAlexis Mollard, Devan Bursey, William Burnett, et al.
Leukemia|November 25, 2023
TP-0184 inhibits FLT3/ACVR1 to overcome FLT3 inhibitor resistance and hinder AML growth synergistically with venetoclaxAnudishi Tyagi, Appalaraju Jaggupilli, Stanley Ly, et al.
Neoplasia (New York, N.Y.)|June 24, 2014
A small-molecule inhibitor of PIM kinases as a potential treatment for urothelial carcinomasJason M Foulks, Kent J Carpenter, Bai Luo, et al.
Pageof 1